567 related articles for article (PubMed ID: 17125270)
1. Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
Heynekamp JJ; Weber WM; Hunsaker LA; Gonzales AM; Orlando RA; Deck LM; Jagt DL
J Med Chem; 2006 Nov; 49(24):7182-9. PubMed ID: 17125270
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.
Kang SS; Cuendet M; Endringer DC; Croy VL; Pezzuto JM; Lipton MA
Bioorg Med Chem; 2009 Feb; 17(3):1044-54. PubMed ID: 18487053
[TBL] [Abstract][Full Text] [Related]
3. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
Banerjee S; Bueso-Ramos C; Aggarwal BB
Cancer Res; 2002 Sep; 62(17):4945-54. PubMed ID: 12208745
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of resveratrol and its analogues by the reaction kinetics of low density lipoprotein peroxidation.
Cheng JC; Fang JG; Chen WF; Zhou B; Yang L; Liu ZL
Bioorg Chem; 2006 Jun; 34(3):142-57. PubMed ID: 16712899
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits NF-kB signaling through suppression of p65 and IkappaB kinase activities.
Ren Z; Wang L; Cui J; Huoc Z; Xue J; Cui H; Mao Q; Yang R
Pharmazie; 2013 Aug; 68(8):689-94. PubMed ID: 24020126
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TNF-α-mediated endothelial cell-monocyte cell adhesion and adhesion molecules expression by the resveratrol derivative, trans-3,5,4'-trimethoxystilbene.
Deng YH; Alex D; Huang HQ; Wang N; Yu N; Wang YT; Leung GP; Lee SM
Phytother Res; 2011 Mar; 25(3):451-7. PubMed ID: 20740479
[TBL] [Abstract][Full Text] [Related]
7. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity.
Kundu JK; Shin YK; Kim SH; Surh YJ
Carcinogenesis; 2006 Jul; 27(7):1465-74. PubMed ID: 16474181
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of a triple-bond resveratrol analog: structure and function relationship.
Antus C; Radnai B; Dombovari P; Fonai F; Avar P; Matyus P; Racz B; Sumegi B; Veres B
Eur J Pharmacol; 2015 Feb; 748():61-7. PubMed ID: 25528327
[TBL] [Abstract][Full Text] [Related]
10. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
11. Different short- and long-term effects of resveratrol on nuclear factor-kappaB phosphorylation and nuclear appearance in human endothelial cells.
Pellegatta F; Bertelli AA; Staels B; Duhem C; Fulgenzi A; Ferrero ME
Am J Clin Nutr; 2003 May; 77(5):1220-8. PubMed ID: 12716675
[TBL] [Abstract][Full Text] [Related]
12. Radical-scavenging activity and mechanism of resveratrol-oriented analogues: influence of the solvent, radical, and substitution.
Shang YJ; Qian YP; Liu XD; Dai F; Shang XL; Jia WQ; Liu Q; Fang JG; Zhou B
J Org Chem; 2009 Jul; 74(14):5025-31. PubMed ID: 19472994
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets.
Kundu JK; Shin YK; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1506-15. PubMed ID: 16999939
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol reduces TNF-α-induced U373MG human glioma cell invasion through regulating NF-κB activation and uPA/uPAR expression.
Ryu J; Ku BM; Lee YK; Jeong JY; Kang S; Choi J; Yang Y; Lee DH; Roh GS; Kim HJ; Cho GJ; Choi WS; Kim N; Kang SS
Anticancer Res; 2011 Dec; 31(12):4223-30. PubMed ID: 22199285
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol enhances ultraviolet B-induced cell death through nuclear factor-kappaB pathway in human epidermoid carcinoma A431 cells.
Roy P; Madan E; Kalra N; Nigam N; George J; Ray RS; Hans RK; Prasad S; Shukla Y
Biochem Biophys Res Commun; 2009 Jun; 384(2):215-20. PubMed ID: 19397895
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of resveratrol-mediated suppression of tissue factor gene expression.
Pendurthi UR; Meng F; Mackman N; Rao LV
Thromb Haemost; 2002 Jan; 87(1):155-62. PubMed ID: 11858183
[TBL] [Abstract][Full Text] [Related]
17. Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor kappaB.
Storz P; Döppler H; Toker A
Mol Pharmacol; 2004 Oct; 66(4):870-9. PubMed ID: 15226414
[TBL] [Abstract][Full Text] [Related]
18. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal BB; Bhardwaj A; Aggarwal RS; Seeram NP; Shishodia S; Takada Y
Anticancer Res; 2004; 24(5A):2783-840. PubMed ID: 15517885
[TBL] [Abstract][Full Text] [Related]
19. 4,4'-Dihydroxy-trans-stilbene, a resveratrol analogue, exhibited enhanced antioxidant activity and cytotoxicity.
Fan GJ; Liu XD; Qian YP; Shang YJ; Li XZ; Dai F; Fang JG; Jin XL; Zhou B
Bioorg Med Chem; 2009 Mar; 17(6):2360-5. PubMed ID: 19251420
[TBL] [Abstract][Full Text] [Related]
20. 3,4,4'-Trihydroxy-trans-stilbene, an analogue of resveratrol, is a potent antioxidant and cytotoxic agent.
Cai W; Zhang L; Song Y; Zhang B; Cui X; Hu G; Fang J
Free Radic Res; 2011 Nov; 45(11-12):1379-87. PubMed ID: 21974738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
